SB
Samsara BioCapital’s Tango Therapeutics TNGX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.08M | Sell |
210,000
-420,000
| -67% | -$2.15M | 0.22% | 23 |
|
2025
Q1 | $863K | Hold |
630,000
| – | – | 0.15% | 26 |
|
2024
Q4 | $1.95M | Hold |
630,000
| – | – | 0.27% | 29 |
|
2024
Q3 | $4.85M | Hold |
630,000
| – | – | 0.93% | 22 |
|
2024
Q2 | $5.41M | Hold |
630,000
| – | – | 1.13% | 21 |
|
2024
Q1 | $5M | Hold |
630,000
| – | – | 0.77% | 23 |
|
2023
Q4 | $6.24M | Hold |
630,000
| – | – | 0.97% | 21 |
|
2023
Q3 | $7.09M | Hold |
630,000
| – | – | 2.17% | 13 |
|
2023
Q2 | $2.09M | Hold |
630,000
| – | – | 0.37% | 29 |
|
2023
Q1 | $2.49M | Hold |
630,000
| – | – | 0.51% | 29 |
|
2022
Q4 | $4.57M | Hold |
630,000
| – | – | 0.98% | 23 |
|
2022
Q3 | $2.28M | Hold |
630,000
| – | – | 0.53% | 34 |
|
2022
Q2 | $2.85M | Hold |
630,000
| – | – | 0.76% | 28 |
|
2022
Q1 | $4.78M | Hold |
630,000
| – | – | 1.2% | 21 |
|
2021
Q4 | $6.89M | Sell |
630,000
-70,000
| -10% | -$766K | 1.34% | 18 |
|
2021
Q3 | $9.05M | Buy |
700,000
+200,000
| +40% | +$2.59M | 1.42% | 16 |
|
2021
Q2 | $5.69M | Hold |
500,000
| – | – | 0.7% | 25 |
|
2021
Q1 | $5.56M | Hold |
500,000
| – | – | 1.03% | 20 |
|
2020
Q4 | $5.72K | Hold |
500,000
| – | – | 0.58% | 20 |
|
2020
Q3 | $5.18M | Buy |
+500,000
| New | +$5.18M | 1.44% | 17 |
|